|
|
golgi to plasma membrane cftr protein transport
|
GO:0043000 |
1 |
0.980
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.775
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.511
|
|
|
|
intermediate filament based process
|
GO:0045103 |
17 |
0.500
|
|
|
|
regulation of ureteric bud formation
|
GO:0072106 |
1 |
0.427
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.375
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.323
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.279
|
|
|
|
intermediate filament bundle assembly
|
GO:0045110 |
5 |
0.260
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.258
|
|
|
|
extraocular skeletal muscle development
|
GO:0002074 |
1 |
0.231
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
73 |
0.228
|
|
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
17 |
0.180
|
|
|
|
keratinization
|
GO:0031424 |
2 |
0.169
|
|
|
|
cytokinesis
|
GO:0000910 |
96 |
0.168
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.159
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.154
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.136
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.129
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.122
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.120
|
|
|
|
post golgi vesicle mediated transport
|
GO:0006892 |
36 |
0.115
|
|
|
|
golgi to plasma membrane protein transport
|
GO:0043001 |
19 |
0.109
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.108
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.101
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.094
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
2 |
0.092
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.092
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.091
|
|
|
|
forebrain dorsal ventral pattern formation
|
GO:0021798 |
1 |
0.090
|
|
|
|
plasma membrane organization
|
GO:0007009 |
115 |
0.089
|
|
|
|
golgi to plasma membrane transport
|
GO:0006893 |
21 |
0.089
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.086
|
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.084
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.083
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.078
|
|
|
|
hair cycle
|
GO:0042633 |
28 |
0.077
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
93 |
0.076
|
|
|
|
intermediate filament organization
|
GO:0045109 |
10 |
0.075
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.072
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
59 |
0.070
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.068
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
121 |
0.067
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
4 |
0.066
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.065
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
63 |
0.062
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.061
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.056
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.056
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.055
|
|
|
|
heart formation
|
GO:0060914 |
2 |
0.052
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.052
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.051
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.051
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.050
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.048
|
|
|
|
mitochondrial membrane organization
|
GO:0007006 |
40 |
0.047
|
|
|
|
golgi vesicle transport
|
GO:0048193 |
80 |
0.047
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
98 |
0.043
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.043
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.043
|
|
|
|
mitochondrial transport
|
GO:0006839 |
60 |
0.043
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
4 |
0.042
|
|
|
|
negative regulation of kidney development
|
GO:0090185 |
2 |
0.042
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
101 |
0.042
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.042
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.041
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.041
|
|
|
|
cranial nerve development
|
GO:0021545 |
4 |
0.040
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.040
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
91 |
0.039
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
70 |
0.038
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.037
|
|
|
|
regulation of mitochondrion organization
|
GO:0010821 |
54 |
0.036
|
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
68 |
0.036
|
|
|
|
muscle organ development
|
GO:0007517 |
56 |
0.036
|
|
|
|
muscle cell development
|
GO:0055001 |
29 |
0.036
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.035
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
4 |
0.035
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.035
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.034
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
68 |
0.034
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.033
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.033
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.033
|
|
|
|
mesonephric tubule formation
|
GO:0072172 |
1 |
0.032
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.032
|
|
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
132 |
0.032
|
|
|
|
positive regulation of cytokinesis
|
GO:0032467 |
29 |
0.030
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.030
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.030
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.030
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.030
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.029
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.029
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.029
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.028
|
|
|
|
rna processing
|
GO:0006396 |
255 |
0.028
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.028
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.028
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.028
|
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.027
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.027
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
3 |
0.027
|
|
|
|
hyperosmotic response
|
GO:0006972 |
4 |
0.027
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.027
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.026
|
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
57 |
0.026
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.026
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.026
|
|
|
|
positive regulation of ureteric bud formation
|
GO:0072107 |
1 |
0.026
|
|
|
|
epithelial cell migration
|
GO:0010631 |
119 |
0.025
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
123 |
0.025
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.025
|
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
71 |
0.025
|
|
|
|
voluntary skeletal muscle contraction
|
GO:0003010 |
1 |
0.025
|
|
|
|
complement activation lectin pathway
|
GO:0001867 |
7 |
0.024
|
|
|
|
single organism membrane fusion
|
GO:0044801 |
37 |
0.024
|
|
|
|
histone methylation
|
GO:0016571 |
60 |
0.024
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
87 |
0.024
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
144 |
0.024
|
|
|
|
regulation of immunoglobulin production
|
GO:0002637 |
4 |
0.024
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.024
|
|
|
|
histone acetylation
|
GO:0016573 |
93 |
0.023
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
101 |
0.023
|
|
|
|
mitotic sister chromatid separation
|
GO:0051306 |
18 |
0.023
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.023
|
|
|
|
glial cell migration
|
GO:0008347 |
4 |
0.023
|
|
|
|
dna replication
|
GO:0006260 |
116 |
0.023
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.023
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.023
|
|
|
|
pituitary gland development
|
GO:0021983 |
2 |
0.023
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
59 |
0.023
|
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.022
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
65 |
0.022
|
|
|
|
skeletal muscle satellite cell proliferation
|
GO:0014841 |
1 |
0.022
|
|
|
|
histone h3 k4 methylation
|
GO:0051568 |
27 |
0.022
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.021
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
103 |
0.021
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.021
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.021
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.021
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.021
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902043 |
3 |
0.020
|
|
|
|
ureteric bud formation
|
GO:0060676 |
1 |
0.020
|
|
|
|
protein activation cascade
|
GO:0072376 |
22 |
0.020
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.020
|
|
|
|
molting cycle
|
GO:0042303 |
28 |
0.020
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
3 |
0.020
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
72 |
0.020
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.020
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.020
|
|
|
|
response to uv
|
GO:0009411 |
73 |
0.020
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.020
|
|
|
|
branch elongation involved in ureteric bud branching
|
GO:0060681 |
2 |
0.019
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.019
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.019
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
42 |
0.019
|
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.018
|
|
|
|
histone h4 acetylation
|
GO:0043967 |
47 |
0.018
|
|
|
|
specification of organ identity
|
GO:0010092 |
3 |
0.018
|
|
|
|
negative regulation of atp catabolic process
|
GO:1903290 |
5 |
0.018
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.018
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.018
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.018
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.018
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
103 |
0.017
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.017
|
|
|
|
anaphase promoting complex dependent proteasomal ubiquitin dependent protein catabolic process
|
GO:0031145 |
25 |
0.017
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
106 |
0.017
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
60 |
0.017
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.017
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.017
|
|
|
|
negative regulation of catabolic process
|
GO:0009895 |
104 |
0.017
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.016
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
33 |
0.016
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.016
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.016
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.016
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.016
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.016
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.016
|
|
|
|
b cell homeostasis
|
GO:0001782 |
1 |
0.016
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.016
|
|
|
|
protein alkylation
|
GO:0008213 |
74 |
0.016
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
71 |
0.016
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
61 |
0.015
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.015
|
|
|
|
protein methylation
|
GO:0006479 |
74 |
0.015
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.015
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.015
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.015
|
|
|
|
regulation of branching involved in ureteric bud morphogenesis
|
GO:0090189 |
3 |
0.015
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
104 |
0.015
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.015
|
|
|
|
wound healing
|
GO:0042060 |
115 |
0.015
|
|
|
|
response to estrogen
|
GO:0043627 |
47 |
0.015
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.015
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.015
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
83 |
0.015
|
|
|
|
spleen development
|
GO:0048536 |
1 |
0.014
|
|
|
|
circadian sleep wake cycle process
|
GO:0022410 |
2 |
0.014
|
|
|
|
nephron tubule formation
|
GO:0072079 |
1 |
0.014
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.014
|
|
|
|
negative regulation of mesonephros development
|
GO:0061218 |
1 |
0.014
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.014
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
24 |
0.014
|
|
|
|
myosin filament organization
|
GO:0031033 |
2 |
0.014
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.014
|
|
|
|
negative regulation of protein kinase activity
|
GO:0006469 |
98 |
0.014
|
|
|
|
rhythmic behavior
|
GO:0007622 |
2 |
0.014
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.014
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
97 |
0.014
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.014
|
|
|
|
long term memory
|
GO:0007616 |
2 |
0.013
|
|
|
|
regulation of mesonephros development
|
GO:0061217 |
3 |
0.013
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
123 |
0.013
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
69 |
0.013
|
|
|
|
short term memory
|
GO:0007614 |
1 |
0.013
|
|
|
|
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway
|
GO:1901030 |
3 |
0.013
|
|
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.013
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.013
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.013
|
|
|
|
negative regulation of t cell receptor signaling pathway
|
GO:0050860 |
4 |
0.013
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
0.013
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.013
|
|
|
|
meiosis i
|
GO:0007127 |
4 |
0.013
|
|
|
|
keratinocyte activation
|
GO:0032980 |
1 |
0.013
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.013
|
|
|
|
mapk export from nucleus
|
GO:0045204 |
1 |
0.013
|
|
|
|
negative regulation of intracellular transport
|
GO:0032387 |
60 |
0.012
|
|
|
|
axoneme assembly
|
GO:0035082 |
3 |
0.012
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.012
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.012
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.012
|
|
|
|
negative regulation of cytoplasmic transport
|
GO:1903650 |
46 |
0.012
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.012
|
|
|
|
regulation of cell cycle arrest
|
GO:0071156 |
36 |
0.012
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
40 |
0.012
|
|
|
|
regulation of atpase activity
|
GO:0043462 |
25 |
0.012
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.012
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
57 |
0.012
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.012
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.012
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.012
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.012
|
|
|
|
negative regulation of leukocyte proliferation
|
GO:0070664 |
16 |
0.011
|
|
|
|
regulation of satellite cell proliferation
|
GO:0014842 |
1 |
0.011
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
55 |
0.011
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.011
|
|
|
|
sarcomere organization
|
GO:0045214 |
8 |
0.011
|
|
|
|
mitochondrial fusion
|
GO:0008053 |
13 |
0.011
|
|
|
|
regulation of dephosphorylation
|
GO:0035303 |
96 |
0.011
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.011
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.011
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.011
|
|
|
|
cell junction assembly
|
GO:0034329 |
67 |
0.011
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
31 |
0.011
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.011
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
10 |
0.011
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.011
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.011
|
|
|
|
replicative cell aging
|
GO:0001302 |
3 |
0.011
|
|
|
|
muscle filament sliding
|
GO:0030049 |
5 |
0.011
|
|
|
|
regulation of chromosome segregation
|
GO:0051983 |
44 |
0.011
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
104 |
0.011
|
|
|
|
aging
|
GO:0007568 |
66 |
0.011
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.010
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
2 |
0.010
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.010
|
|
|
|
histone threonine phosphorylation
|
GO:0035405 |
7 |
0.010
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
15 |
0.010
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.010
|
|
|
|
positive regulation of mesenchymal stem cell differentiation
|
GO:2000741 |
4 |
0.010
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.010
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.010
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
85 |
0.010
|
|
|
|
thymus development
|
GO:0048538 |
3 |
0.010
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
77 |
0.010
|
|